Boston Life Sciences, Inc. Announces Webcast of 2007 Annual Meeting

HOPKINTON, Mass., June 5  /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that the Company will provide a corporate and program update following the formal proceedings of its Annual Meeting of Stockholders.   The update presentation will be webcast.  The meeting is being held on Thursday, June 7, 2007 at 1:00 pm. EDT at the offices of Wilmer Cutler Pickering Hale & Dorr, 60 State Street, Boston, MA.

The webcast is expected to begin at approximately 1:15 p.m. EST and can be accessed at https://www.livemeeting.com/cc/vcc/join Meeting ID: w5242328, Meeting Key: A524232, Participant Code: 5242328.  Audio can be heard at 800-289-0485 Passcode: 5242328.  The webcast and audio replay will be available on the Investor Relations section of the Company's website within 48 hours http://www.bostonlifesciences.com/ . The event will be archived and available for replay through June 21, 2007.

About Boston Life Sciences, Inc.

Boston Life Sciences, Inc. (BLSI) is engaged in the research and clinical development of diagnostic and therapeutic products for central nervous system (CNS) disorders. Cethrin(R), a recombinant-protein-based drug designed to promote nerve repair after acute spinal cord injury, has reported positive interim results in a Phase I/IIa clinical trial. ALTROPANE(R) molecular imaging agent is in Phase III clinical trials for the diagnosis of Parkinson's Disease (PD).  The company's research and pre-clinical CNS programs include Inosine for the treatment of spinal cord injury and stroke, a DAT blocker for the treatment of Parkinson's disease, and a second generation technetium-based molecular imaging agent for PD and ADHD.  BLSI's current research collaborations include Harvard Medical School and Children's Hospital Boston.

  Contact:
  Sharon Correia
  Director, Corporate Communications
  508-497-2360 ext 224
  

DATASOURCE: Boston Life Sciences, Inc.



CONTACT:  Sharon Correia, Director, Corporate Communications of Boston

Life Sciences, Inc., [phone], ext. 224,

 



Web site:  http://www.bostonlifesciences.com/

https://www.livemeeting.com/cc/vcc/join 

Copyright